BSE Live
Jan 16, 16:01Prev. Close
6356.75
Open Price
6317.20
Bid Price (Qty.)
6233.95 (2)
Offer Price (Qty.)
6233.95 (6)
NSE Live
Jan 16, 15:54Prev. Close
6355.50
Open Price
6355.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Divis Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 64.15 | 58.26 | 45.35 | 40.19 | 32.42 | |
| Diluted EPS (Rs.) | 64.15 | 58.26 | 45.35 | 40.19 | 32.41 | |
| Cash EPS (Rs.) | 74.40 | 65.20 | 51.15 | 44.85 | 36.40 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 263.33 | 223.25 | 188.39 | 160.59 | 135.56 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 263.33 | 223.25 | 188.39 | 160.59 | 135.56 | |
| Revenue from Operations/Share (Rs.) | 234.67 | 190.77 | 161.59 | 140.43 | 99.29 | |
| PBDIT/Share (Rs.) | 91.15 | 81.75 | 64.79 | 56.24 | 39.77 | |
| PBIT/Share (Rs.) | 80.91 | 74.81 | 58.99 | 51.56 | 35.74 | |
| PBT/Share (Rs.) | 80.77 | 74.65 | 58.86 | 51.28 | 35.63 | |
| Net Profit/Share (Rs.) | 64.15 | 58.26 | 45.35 | 40.18 | 32.37 | |
| NP After MI And SOA / Share (Rs.) | 64.15 | 58.26 | 45.35 | 40.18 | 32.37 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 38.84 | 42.85 | 40.09 | 40.04 | 40.05 | |
| PBIT Margin (%) | 34.47 | 39.21 | 36.50 | 36.71 | 35.99 | |
| PBT Margin (%) | 34.41 | 39.13 | 36.42 | 36.51 | 35.87 | |
| Net Profit Margin (%) | 27.33 | 30.54 | 28.06 | 28.60 | 32.60 | |
| NP After MI And SOA Margin (%) | 27.33 | 30.54 | 28.06 | 28.60 | 32.60 | |
| Return on Networth/Equity (%) | 24.36 | 26.09 | 24.07 | 25.01 | 23.88 | |
| Return on Capital Employed (%) | 23.46 | 25.08 | 23.29 | 24.20 | 23.01 | |
| Return on Assets (%) | 19.33 | 20.84 | 19.17 | 19.34 | 18.87 | |
| Total Debt/Equity (X) | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | |
| Asset Turnover Ratio (%) | 70.71 | 68.24 | 68.33 | 67.61 | 57.87 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 3.57 | 3.62 | 3.36 | 3.16 | 3.76 | |
| Quick Ratio (X) | 2.08 | 2.14 | 1.85 | 1.94 | 2.36 | |
| Inventory Turnover Ratio (X) | 2.68 | 2.72 | 2.57 | 2.75 | 2.30 | |
| Dividend Payout Ratio (NP) (%) | 31.17 | 34.32 | 33.07 | 32.35 | 30.88 | |
| Dividend Payout Ratio (CP) (%) | 26.88 | 30.67 | 29.32 | 28.98 | 27.47 | |
| Earnings Retention Ratio (%) | 68.83 | 65.68 | 66.93 | 67.65 | 69.12 | |
| Cash Earnings Retention Ratio (%) | 73.12 | 69.33 | 70.68 | 71.02 | 72.53 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 575.99 | 483.15 | 440.76 | 182.83 | 312.49 | |
| Interest Coverage Ratios (Post Tax) (%) | 575.99 | 483.15 | 440.76 | 182.83 | 312.49 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 23,722.37 | 18,148.72 | 13,048.82 | 10,197.92 | 8,962.97 | |
| EV/Net Operating Revenue (X) | 7.62 | 7.17 | 6.08 | 5.47 | 6.81 | |
| EV/EBITDA (X) | 19.61 | 16.73 | 15.17 | 13.66 | 17.00 | |
| MarketCap/Net Operating Revenue (X) | 7.63 | 7.18 | 6.09 | 5.46 | 6.81 | |
| Retention Ratios (%) | 68.82 | 65.67 | 66.92 | 67.64 | 69.11 | |
| Price/BV (X) | 6.80 | 6.13 | 5.22 | 4.77 | 4.99 | |
| Price/Net Operating Revenue | 7.63 | 7.18 | 6.09 | 5.46 | 6.81 | |
| Earnings Yield | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 |
20.11.2025
Accumulate Divis Laboratories; target of Rs 6795: Deven Choksey
14.11.2025
Divis Labs Consolidated September 2025 Net Sales at Rs 2,715.00 crore, up 16.12% Y-o-Y
12.11.2025
Neutral Divis Laboratories; target of Rs 6925: Motilal Oswal
12.11.2025
Divis Labs Standalone September 2025 Net Sales at Rs 2,660.00 crore, up 15.55% Y-o-Y
24.05.2024
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
04.11.2023
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
14.08.2023
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
19.05.2023
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill